Cover Image
市場調查報告書

生菌試驗的全球市場 2019年:各產品 (檢查裝置、消耗品)、各實驗項目 (需氣性菌、厭氧菌、真菌、孢子)、各用途 、各終端用戶的未來預測

Bioburden Testing Market by Product [Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)], Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) - Forecast to 2019

出版商 MarketsandMarkets 商品編碼 330568
出版日期 內容資訊 英文 146 Pages
訂單完成後即時交付
價格
Back to Top
生菌試驗的全球市場 2019年:各產品 (檢查裝置、消耗品)、各實驗項目 (需氣性菌、厭氧菌、真菌、孢子)、各用途 、各終端用戶的未來預測 Bioburden Testing Market by Product [Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)], Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) - Forecast to 2019
出版日期: 2015年05月14日 內容資訊: 英文 146 Pages
簡介

全球生菌試驗市場,2014年達到3億5440萬美元,預計2019年達到5億6560萬美元的規模,其間的年複合成長率(CAGR) 為9.8%。市場成長的主要的推動因素,為醫療設備產業的成長,及製藥、生物科技產業的趨勢變化,對食品安全的不安擴大,對生命科學領域的研究開發 (R&D) 投資擴大,微生物污染的產品回收數量增加等。另一方面,檢查裝置的成本高和複雜性,嚴格的法規,核准時間長等成為抑制市場成長率的要素。現在北美是全球最大的市場,不過,亞太地區也正在急速趕上。

本報告提供全球的生菌試驗 (污染微生物數檢驗) 的市場相關分析、市場基本結構和最新趨勢、主要市場促進、阻礙因素、市場規模趨勢預測 (今後6年份)、各產品、檢驗的各類型、各用途、各終端用戶、各地區的詳細趨勢、市場競爭的狀態、今後的技術開發、市場發展的方向性、主要企業簡介等調查、考察。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 推動因素
      • 醫療設備、製藥、生物科技產業的成長
      • 食品、飲料的安全性相關疑慮的增加
      • 微生物污染的產品回收數量增加
      • 在生命科學領域活躍的研究開發 (R&D) 投資的動向
      • 醫療產業發達和醫療費的增加
    • 阻礙因素
      • 微生物計數設備的價格高
    • 機會
      • 醫藥品受託製造廠商 (CMO) 市場機會
      • 新興國家市場
    • 課題
      • 知識、熟練人力資源的不足
      • 對實驗設備、消耗品的嚴格法規政策

第6章 產業考察

  • 波特的五力分析
  • 策略性基準

第7章 生菌試驗市場:各產品

  • 簡介
  • 消耗品
    • 培養基、試劑、套件
    • 其他的消耗品
  • 實驗器具
    • PCR (聚合酵素鏈鎖反應)
    • 顯微鏡
    • 自動微生物鑑定系統
    • 其他器具

第8章 生菌試驗市場:檢驗的各類型

  • 簡介
  • 需氣性菌數
  • 厭氧菌數
  • 真菌/黴菌數
  • 孢子價值

第9章 生菌試驗市場:各用途

  • 簡介
  • 原料實驗
  • 醫療設備實驗
  • 中間產品的檢驗
  • 殺菌驗證實驗
  • 設備的清洗驗證

第10章 生菌試驗市場:各終端用戶

  • 簡介
  • 醫藥品、生物科技企業
  • 醫療設備廠商
  • 醫藥品受託製造廠商 (CMO)
  • 食品、飲料及農產品廠商
  • 微生物實驗機關

第11章 地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
  • 亞洲
  • 其他地區 (RoW)

第12章 競爭情形

  • 概要
  • 競爭情形、趨勢
    • 企業收購
    • 新產品與服務的銷售
    • 產業擴張
    • 其他

第13章 企業簡介

  • 簡介
  • Charles River Laboratories International, Inc.
    • 產業概要
    • 產品與服務
    • 最近的發展趨勢
    • MnM的見解
  • Sigma-Aldrich Corporation
  • SGS S.A.
  • WUXI Pharmatech (Cayman), Inc.
  • Merck & Co., Inc
  • Becton, Dickinson, and Company
  • North American Science Associates, Inc. (NAMSA)
  • Nelson Laboratories, Inc.
  • Pacific Biolabs
  • ATS Labs, Inc.

第14章 附錄

圖表一覽

目錄
Product Code: BT 3394

The bioburden testing market is expected to reach $565.6 million by 2019 from $354.4 million in 2014, at a CAGR of 9.8% from 2014 to 2019. This market is segmented on the basis of products, test types, applications, end users, and regions. On the basis of end users, the market is segmented into pharmaceutical and biotechnology companies, medical device manufacturers, contract manufacturing organizations (CMOs), manufacturers of food & beverage and agricultural products, and microbial testing laboratories. The CMOs segment is expected to grow at the highest CAGR in the coming five years. Growth in this segment will be driven by the rising demand for cost-effective alternatives for manufacturing in emerging as well as developed countries.

The major factors contributing to the growth of the global bioburden testing market include the growing medical device industry, changing trends in the pharmaceutical and biotechnology industries, increasing food safety concerns to boost the microbial identification market, strong trend of R&D investments in life sciences, and increasing product recalls due to microbial contamination. However, high cost of instruments and complex and time-consuming regulatory standards to lengthen the approval process in some countries may hinder the growth of this market.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the bioburden testing market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make necessary decisions regarding product offerings, geographical focus, change in strategic approach, and R&D investments for innovations in products and technologies and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the bioburden testing market. The report analyzes the market by product, test type, application, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the bioburden testing market
  • Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the bioburden testing market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various bioburden testing products across regions
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the bioburden testing market

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Scope
    • 1.3.1. Markets Covered
    • 1.3.2. Years Considered for the Study
  • 1.4. Currency
  • 1.5. Limitations
  • 1.6. Market Stakeholders

2. Research Methodology

  • 2.1. Market Size Estimation
  • 2.2. Market Breakdown & Data Triangulation
  • 2.3. Key Data From Secondary Sources
  • 2.4. Key Data From Primary Sources
  • 2.5. Key Industry Insights
  • 2.6. Assumptions for the Study

3. Executive Summary

4. Premium Insights

  • 4.1. Bioburden Testing Market, By Product
  • 4.2. Bioburden Testing Market, for Instruments
  • 4.3. Bioburden Testing Market, By Test Types
  • 4.4. Bioburden Testing Market, By Applications
  • 4.5. Geographic Snapshot
  • 4.6. Bioburden Testing Market, By End Users

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Segmentation
    • 5.2.1. Bioburden Testing Market By Product
    • 5.2.2. Bioburden Testing Market By Test Type
    • 5.2.3. Bioburden Testing Market By Application
    • 5.2.4. Bioburden Testing Market By End User
    • 5.2.5. Bioburden Testing Market By Region
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
      • 5.3.1.1. Growing Medical Device, Pharmaceutical and Biotechnology Industries
      • 5.3.1.2. Increasing Food & Beverage Safety Concerns
      • 5.3.1.3. Increasing Product Recall Due to Microbial Contamination
      • 5.3.1.4. Strong Trend of R&D Investments in Life Sciences
      • 5.3.1.5. Growing Healthcare Industry and Medical Spending
    • 5.3.2. Restrain
      • 5.3.2.1. High Costs of Microbial Enumeration Instruments
    • 5.3.3. Opportunities
      • 5.3.3.1. Opportunity in Contract Manufacturing Market
      • 5.3.3.2. Emerging Economies
    • 5.3.4. Challenges
      • 5.3.4.1. Shortage of Knowledgeable and Skilled Professionals
      • 5.3.4.2. Stringent Regulatory Policies for Instruments and Consumables

6. Industry Insights

  • 6.1. Porter's Five Forces Analysis
    • 6.1.1. Threat From New Entrants
    • 6.1.2. Threat From Substitutes
    • 6.1.3. Bargaining Power of Suppliers
    • 6.1.4. Bargaining Power of Buyers
    • 6.1.5. Intensity of Competitive Rivalry
  • 6.2. Strategic Benchmarking

7. Bioburden Testing Market, By Product

  • 7.1. Introduction
  • 7.2. Consumables
    • 7.2.1. Culture Media, Reagents & Kits
    • 7.2.2. Other Consumables
  • 7.3. Instruments
    • 7.3.1. PCR
    • 7.3.2. Microscopes
    • 7.3.3. Automated Microbial Identification Systems
    • 7.3.4. Other Instruments

8. Bioburden Testing Market, By Test Type

  • 8.1. Introduction
  • 8.2. Aerobic Count
  • 8.3. Anaerobic Count
  • 8.4. Fungi / Mold Count
  • 8.5. Spore Count

9. Bioburden Testing Market, By Application

  • 9.1. Introduction
  • 9.2. Raw Materials Testing
  • 9.3. Medical Devices Testing
  • 9.4. In-Process Material Testing
  • 9.5. Sterilization Validation Testing
  • 9.6. Equipment Cleaning Validation

10. Bioburden Testing Market, By End User

  • 10.1. Introduction
  • 10.2. Pharmaceutical & Biotechnology Companies
  • 10.3. Medical Device Manufacturers
  • 10.4. Contract Manufacturing Organizations (CMOS)
  • 10.5. Manufacturers of Food & Eberage and Agriculture Products
  • 10.6. Microbial Testing Laboratories

11. Geographic Analysis

  • 11.1. Introduction
  • 11.2. North America
    • 11.2.1. U.S.
    • 11.2.2. Canada
  • 11.3. Europe
  • 11.4. Asia
  • 11.5. Rest of the World (RoW)

12. Competitive Landscape

  • 12.1. Overview
  • 12.2. Competitive Situation and Trends
    • 12.2.1. Acquisitions
    • 12.2.2. New Product and Service Launches
    • 12.2.3. Expansion
    • 12.2.4. Others

13. Company Profiles

  • 13.1. Introduction
  • 13.2. Charles River Laboratories International, Inc.
    • 13.2.1. Business Overview
    • 13.2.2. Products & Services
    • 13.2.3. Recent Developments
    • 13.2.4. MnM View
  • 13.3. Sigma-Aldrich Corporation
    • 13.3.1. Business Overview
    • 13.3.2. Products & Services
    • 13.3.3. Recent Developments
    • 13.3.4. MnM View
  • 13.4. SGS S.A.
    • 13.4.1. Business Overview
    • 13.4.2. Services
    • 13.4.3. Recent Developments
    • 13.4.4. MnM View
  • 13.5. WUXI Pharmatech (Cayman), Inc.
    • 13.5.1. Business Overview
    • 13.5.2. Services
    • 13.5.3. Recent Developments
    • 13.5.4. MnM View
  • 13.6. Merck & Co., Inc.
    • 13.6.1. Business Overview
    • 13.6.2. Products & Services
    • 13.6.3. Recent Developments
    • 13.6.4. MnM View
  • 13.7. Becton, Dickinson, and Company
    • 13.7.1. Business Overview
    • 13.7.2. Product & Services
    • 13.7.3. Key Strategy
    • 13.7.4. Recent Developments
  • 13.8. North American Science Associates, Inc. (NAMSA)
    • 13.8.1. Business Overview
    • 13.8.2. Services
    • 13.8.3. Key Strategy
    • 13.8.4. Recent Developments
  • 13.9. Nelson Laboratories, Inc.
    • 13.9.1. Business Overview
    • 13.9.2. Services
    • 13.9.3. Key Strategy
    • 13.9.4. Recent Developments
  • 13.10. Pacific Biolabs
    • 13.10.1. Business Overview
    • 13.10.2. Service Portfolio
    • 13.10.3. Key Strategy
    • 13.10.4. Recent Developments
  • 13.11. ATS Labs, Inc.
    • 13.11.1. Business Overview
    • 13.11.2. Services
    • 13.11.3. Key Strategy
    • 13.11.4. Recent Developments

14. Appendix

List of Tables

  • Table 1: Growing Medical Device, Pharmaceutical and Biotechnology Industries Propelling the Growth of the Bioburden Testing Market
  • Table 2: High Costs of Microbial Enumeration Instruments to Hinder Market Growth
  • Table 3: Contract Manufacturing to Create New Growth Opportunities for Market
  • Table 4: Shortage of Knowledgeable and Skilled Professionals A Major Challenge for the Market
  • Table 5: Microbial Limit Testing Market Size, By Product 2012-2019 ($Million)
  • Table 6: Market Size for Consumables, By Type, 2012-2019 ($Million)
  • Table 7: Microbial Limit Testing Market Size for Consumables, By Region, 2012-2019 ($Million)
  • Table 8: North America: Market Size for Consumables, By Country, 2012-2019 ($Million)
  • Table 9: Market Size for Culture Media, Reagents & Kits, By Region, 2012-2019 ($Million)
  • Table 10: North America: Market Size for Culture Media, Reagents & Kits, By Region, 2012-2019 ($Million)
  • Table 11: Market Size for Other Consumables, By Region, 2012-2019 ($Million)
  • Table 12: North America: Market Size for Other Consumables, By Country, 2012-2019 ($Million)
  • Table 13: Bioburden Testing Market Size for Instruments, By Type, 2012-2019 ($Million)
  • Table 14: Market Size for Instruments, By Region, 2012-2019 ($Million)
  • Table 15: North America: Market Size for Instruments, By Country, 2012-2019 ($Million)
  • Table 16: Microbial Limit Testing Market Size for PCR, By Region, 2012-2019 ($Million)
  • Table 17: North America: Bioburden Testing Market Size for PCR, By Country, 2012-2019 ($Million)
  • Table 18: Market Size for Microscopes, By Region, 2012-2019 ($Million)
  • Table 19: North America: Bioburden Testing Market Size for Microscopes, By Country, 2012-2019 ($Million)
  • Table 20: Market Size for Automated Microbial Identification System, By Region, 2012-2019 ($Million)
  • Table 21: North America: Bioburden Testing Market Size for Automated Microbial Identification System, By Country, 2012-2019 ($Million)
  • Table 22: Market Size for Other Instruments, By Region, 2012-2019 ($Million)
  • Table 23: North America: Bioburden Testing Market Size for Other Instruments, By Country, 2012-2019 ($Million)
  • Table 24: Market Size, By Test 2012-2019 ($Million)
  • Table 25: Microbial Limit Testing Market Size for Aerobic Count, By Region, 2012-2019 ($Million)
  • Table 26: North America: Market Size for Aerobic Count, By Country, 2012-2019 ($Million)
  • Table 27: Bioburden Testing Market Size for Anaerobic Count, By Region, 2012-2019 ($Million)
  • Table 28: North America: Bioburden Testing Market Size for Anaerobic Count, By Country, 2012-2019 ($Million)
  • Table 29: Market Size for Fungi/Mold Count, By Region, 2012-2019 ($Million)
  • Table 30: North America: Microbial Limit Testing Market Size for Fungi/Mold Count, By Country, 2012-2019 ($Million)
  • Table 31: Market Size for Spore Count, By Region, 2012-2019 ($Million)
  • Table 32: North America: Bioburden Testing Market Size for Spore Count, By Country, 2012-2019 ($Million)
  • Table 33: Microbial Limit Testing Market Size, By Application 2012-2019 ($Million)
  • Table 34: Market Size for Raw Materials Testing, By Region, 2012-2019 ($Million)
  • Table 35: North America: Market Size for Raw Materials Testing, By Country, 2012-2019 ($Million)
  • Table 36: Market Size for Medical Devices Testing, By Region, 2012-2019 ($Million)
  • Table 37: North America: Bioburden Testing Market Size for Medical Devices Testing, By Country, 2012-2019 ($Million)
  • Table 38: Microbial Limit Testing Market Size for In-Process Testing, By Region, 2012-2019 ($Million)
  • Table 39: North America: Bioburden Testing Market Size for In-Process Testing, By Country, 2012-2019 ($Million)
  • Table 40: Microbial Limit Testing Market Size for Sterilization Validation Testing, By Region, 2012-2019 ($Million)
  • Table 41: North America: Market Size for Sterilization Validation Testing, By Country, 2012-2019 ($Million)
  • Table 42: Bioburden Testing Market Size for Equipment Cleaning Validation, By Region, 2012-2019 ($Million)
  • Table 43: North America: Market Size for Equipment Cleaning Validation , By Country, 2012-2019 ($Million)
  • Table 44: Bioburden Testing Market Size, By End User 2012-2019 ($Million)
  • Table 45: Microbial Limit Testing Market Size for Pharmaceutical Companies & Biotechnology Companies, By Region, 2012-2019 ($Million)
  • Table 46: North America: Bioburden Testing Market Size for Pharmaceutical Companies & Biotechnology Companies, By Country, 2012-2019 ($Million)
  • Table 47: Market Size for Medical Device Manufacturers, By Region, 2012-2019 ($Million)
  • Table 48: North America: Bioburden Testing Market Size for Medical Device Manufacturers, By Country, 2012-2019 ($Million)
  • Table 49: Market Size for CMOS, By Region, 2012-2019 ($Million)
  • Table 50: North America: Bioburden Testing Market Size for CMOS, By Country, 2012-2019 ($Million)
  • Table 51: Market Size for Manufacturers of Food & beverage and Agriculture Products, By Region, 2012-2019 ($Million)
  • Table 52: North America: Microbial Limit Testing Market Size for Manufacturers of Food & beverage and Agriculture Products, By Country, 2012-2019 ($Million)
  • Table 53: Market Size for Microbial Testing Labs, By Region, 2012-2019 ($Million)
  • Table 54: North America: Bioburden Testing Market Size for Microbial Testing Labs, By Country, 2012-2019 ($Million)
  • Table 55: Market Size, By Region 2012-2019 ($Million)
  • Table 56: North America: Microbial Limit Testing Market Size, By Country 2012-2019 ($Million)
  • Table 57: North America: Market Size, By Product 2012-2019 ($Million)
  • Table 58: North America: Bioburden Testing Consumables Market Size, By Type 2012-2019 ($Million)
  • Table 59: North America: Bioburden Testing Instruments Market Size, By Type 2012-2019 ($Million)
  • Table 60: North America: Market Size, By Test 2012-2019 ($Million)
  • Table 61: North America: Market Size, By Application 2012-2019 ($Million)
  • Table 62: North America: Microbial Limit Testing Market Size, By End User 2012-2019 ($Million)
  • Table 63: U.S.: Market Size, By Product 2012-2019 ($Million)
  • Table 64: U.S.: Bioburden Testing Consumables Market Size, By Type 2012-2019 ($Million)
  • Table 65: U.S.: Bioburden Testing Instruments Market Size, By Type 2012-2019 ($Million)
  • Table 66: U.S.: Market Size, By Test 2012-2019 ($Million)
  • Table 67: U.S.: Market Size, By Application 2012-2019 ($Million)
  • Table 68: U.S.: Microbial Limit Testing Market Size, By End User 2012-2019 ($Million)
  • Table 69: Canada: Market Size, By Product 2012-2019 ($Million)
  • Table 70: Canada: Bioburden Testing Consumables Market Size, By Type 2012-2019 ($Million)
  • Table 71: Canada: Bioburden Testing Instruments Market Size, By Type 2012-2019 ($Million)
  • Table 72: Canada: Market Size, By Test 2012-2019 ($Million)
  • Table 73: Canada: Microbial Limit Testing Market Size, By Application 2012-2019 ($Million)
  • Table 74: Canada: Microbial Limit Testing Market Size, By End User 2012-2019 ($Million)
  • Table 75: Europe: Market Size, By Product 2012-2019 ($Million)
  • Table 76: Europe: Bioburden Testing Consumables Market Size, By Type 2012-2019 ($Million)
  • Table 77: Europe: Bioburden Testing Instruments Market Size, By Type 2012-2019 ($Million)
  • Table 78: Europe: Microbial Limit Testing Market Size, By Test 2012-2019 ($Million)
  • Table 79: Europe: Microbial Limit Testing Market Size, By Application 2012-2019 ($Million)
  • Table 80: Europe: Market Size, By End User 2012-2019 ($Million)
  • Table 81: Asia: Market Size, By Product 2012-2019 ($Million)
  • Table 82: Asia: Bioburden Testing Consumables Market Size, By Type 2012-2019 ($Million)
  • Table 83: Asia: Bioburden Testing Instruments Market Size, By Type 2012-2019 ($Million)
  • Table 84: Asia: Market Size, By Test 2012-2019 ($Million)
  • Table 85: Asia: Market Size, By Application 2012-2019 ($Million)
  • Table 86: Asia: Market Size, By End User 2012-2019 ($Million)
  • Table 87: RoW: Market Size, By Product 2012-2019 ($Million)
  • Table 88: RoW: Bioburden Testing Consumables Market Size, By Type 2012-2019 ($Million)
  • Table 89: RoW: Bioburden Testing Instruments Market Size, By Type 2012-2019 ($Million)
  • Table 90: RoW: Market Size, By Test 2012-2019 ($Million)
  • Table 91: RoW: Microbial Limit Testing Market Size, By Application 2012-2019 ($Million)
  • Table 92: RoW: Microbial Limit Testing Market Size, By End User 2012-2019 ($Million)
  • Table 93: Recent Acquisitions
  • Table 94: Recent Product and Service Launches
  • Table 95: Recent Expansion
  • Table 96: Recent Other Strategies

List of Figures

  • Figure 1: Research Methodology
  • Figure 2: Top-Down Approach
  • Figure 3: Bottom-Up Approach
  • Figure 4: Breakdown of Primary Interviews: By Company Type, Designation, and Region
  • Figure 5: Bioburden Testing Market Snapshot, By Product (2014 vs. 2019): Consumables Segment to Dominate the Market During the Forecast Period
  • Figure 6: Market Snapshot, By Test (2014 vs. 2019): Aerobic Count Segment to Witness Highest Growth
  • Figure 7: Market Snapshot, By Application (2014 vs. 2019): Raw Material Testing Segment is Dominant in the Market
  • Figure 8: Pharmeceutical and Biotechnology Companies Held the Largest Share of the Bioburden Testing Market in 2014
  • Figure 9: Global Market, By Region, 2014: North America Accounted for the Largest Share While Asia is Expected to Grow at A Highest CAGR From 2014-2019
  • Figure 10: Consumables Offers Attractive Market Opportunities
  • Figure 11: PCR Segment to Grow at Highest CAGR
  • Figure 12: Culture Media, Reagents and Kits Segment to Grow at Highest CAGR
  • Figure 13: Aerobic Count to Grow at Highest CAGR
  • Figure 14: Raw Material Testing to Account for the Largest Share of the Market
  • Figure 15: Asia to Dominate Bioburden Testing Market
  • Figure 16: Pharmaceutical Companies & Biotechnology Companies Offer Highest Growth Opportunities
  • Figure 17: Bioburden Testing Market Segmentation By Product
  • Figure 18: Market Segmentation By Test Type
  • Figure 19: Market Segmentation By Application
  • Figure 20: Market Segmentation By End User
  • Figure 21: Market Segmentation By Region
  • Figure 22: Growing Medical Device, Pharmaceutical and Biotechnology Industries to Fuel Market Growth
  • Figure 23: Porter's Five Forces Analysis
  • Figure 24: Strategic Benchmarking: Top Players Adopted Acquisitions as Key Growth Strategies
  • Figure 25: Consumables Market to Witness Significant Growth in the Forecast Period
  • Figure 26: Asia to Record the Highest Growth Rate in the Consumables Market
  • Figure 27: Asia Will Grow at Highest CAGR in the Forecast Period 2015-2019
  • Figure 28: Raw Materials Testing Segment to Witness Growth in the Forecast Period
  • Figure 29: CMOS are Expected Grow at the Highest CAGR
  • Figure 30: Asian Market for Bioburden Testing is Expected to Grow at Highest Rate From 2014 to 2019
  • Figure 31: Asia: High Demand for Veterinary Software From End Users
  • Figure 32: North America: Market Snapshot
  • Figure 33: Major Players Adopted Acquisitions and New Product and Service Launches as A Key Growth Strategy Between 2012 and 2014
  • Figure 34: Market Evolution Framework: Acquisitions and Product and Service Launches Fuelled Market Growth
  • Figure 35: Acquisitions, New Product and Service Launches Were Preferred Strategies for Market Players
  • Figure 36: Geographic Revenue Mix of Top 4 Market Players
  • Figure 37: Charles River Laboratories International, Inc.: Company Snapshot
  • Figure 38: Sigma-Aldrich Corporation: Company Snapshot
  • Figure 39: SGS SA: Company Snapshot
  • Figure 40: WUXI Pharmatech (Cayman) Inc.: Company Snapshot
  • Figure 41: Merck & Co., Inc.: Company Snapshot
  • Figure 42: Becton, Dickinson and Company: Company Snapshot
  • Figure 43: North American Science Associates, Inc.: Company Snapshot
  • Figure 44: Nelson Laboratories Inc.: Company Snapshot
  • Figure 45: Pacific Biolabs: Company Snapshot
  • Figure 46: ATS Labs, Inc.: Company Snapshot
Back to Top